Jiangsu Superbio Biomedical Co., Ltd.

What Jiangsu Superbio Biomedical Co., Ltd. does

Jiangsu Superbio Biomedical Co., Ltd. is a privately held Chinese biomedical company founded in August 2011 and headquartered at No. 1 Shuishan Avenue, Software and Service Outsourcing Industrial Park, Suqian City, Jiangsu Province. The company develops, manufactures, and sells gene sequencing technology products and equipment, organized around two primary verticals: medical services (medical aesthetics and health, anesthesia and respiratory, interventional medical devices) and forensic identification (DNA analysis reagents, genetic analyzers, forensic lab construction, drug abuse testing). The company also markets several adjacent medical device categories including protection and disinfection products, three-lumen gastric tubes, and interventional polymer materials.

The product portfolio is centered on gene sequencing technology. Forensic reagents include Y-series (Y-com, Y62, Y44SE-PLUS, Y41SE), X-series (X31Plex, X18), A-series (A33 in standard and lyophilized formats, A27Plex, A33Plex, 21plex), and NC22 kits, offered in multiple configurations including 6-color, 8-color, and varying multiplex densities for DNA analysis in criminal casework and paternity/identification workflows. The genetic analyzer line comprises five instruments (H1624, 1824-2, 1816-2, 1696, 1616-2) for capillary electrophoresis-based DNA sequencing and fragment analysis. Complementary offerings include complete forensic laboratory construction services and drug abuse testing products.

Superbio operates a direct-sales model with global online inquiry functionality on all product pages, supported by a website product catalog and a LinkedIn corporate presence. The company claims a 45,000+ square meter factory footprint, 600+ employees, 1,500+ cooperation units (including domestic universities and research institutions), and annual revenue of 5+ hundred million RMB (~US$70M+) on its homepage. It holds FDA 21 CFR Part 11, ISO 13485, and CE certifications, supporting sales into U.S., European, and broader regulated markets. The company is privately held with no public listing, no disclosed venture capital or private equity funding rounds, and no M&A activity evidenced in the available data.

Name

Jiangsu Superbio Biomedical Co., Ltd.

Legal name

Jiangsu Superbio Biomedical Co., Ltd.

Website

https://ensuperbio.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Jiangsu Superbio Biomedical is a privately held Chinese biomedical company founded in 2011 that develops gene sequencing reagents, genetic analyzers, and forensic DNA testing products for medical and forensic identification markets, selling directly through global online inquiry channels.

Ownership category

akta.pro rank

Product category

Forensic & Genetic Analysis Equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

akta.pro secondary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Forensic DNA analysis
• Genetic analyzers
• Gene sequencing equipment
• Forensic lab construction
• Drug abuse testing

Headquarters

HQ city

Suqian City

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Gene Sequencing Products and Equipment Sales: The company generates revenue through development, production, and sales of gene sequencing technology, products, and equipment for medical services and forensic identification fields.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Jiangsu Superbio develops, produces, and sells gene sequencing technology, products, and equipment for the medical services and forensic identification fields. Its product portfolio comprises forensic DNA analysis reagent kits, genetic analyzers (DNA sequencing instruments), drug abuse test products, and end-to-end forensic laboratory construction services, alongside additional medical device lines covering medical aesthetics, anesthesia/respiratory, protection/disinfection, and interventional medical products.

Product overview

Jiangsu Superbio Biomedical Co., Ltd. is a high-tech enterprise focused on the development, production, sales, and technical services of gene sequencing technology, products, and equipment. The company offers a multi-product portfolio consisting of: (1) Forensic Services Products including Y-series (Y-com, Y62, Y44SE-PLUS, y41se), X-series (X31Plex, X18), A-series (A33, A33Plex, A27Plex, 21plex), and NC22 reagents for DNA analysis and genetic identification in forensic investigations, available in various configurations including standard, lyophilized, and multiplex formats with different color case options; (2) Genetic Analyzers including H1624, 1824-2, 1816-2, 1696, and 1616-2 instruments for DNA sequencing and genetic analysis; (3) Forensic Lab Construction services for building complete forensic identification facilities; and (4) Drug Abuse Test products for substance detection. The company operates primarily in medical services and forensic identification fields, with additional product lines in medical aesthetics, anesthesia/respiratory, protection/disinfection, and intervention medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Forensic Services Products (DNA Analysis Reagent Kits) A portfolio of forensic DNA analysis reagent kits (multiplex PCR kits, lyophilized reagents, and 6/8-color casework kits) used by forensic laboratories, law enforcement agencies, and forensic identification units for DNA analysis, genetic identification, and casework applications.
• Genetic Analyzers Genetic analyzer instruments (models H1624, 1824-2, 1816-2, 1696, 1616-2) used by forensic laboratories, medical institutions, and research facilities for DNA sequencing, genetic analysis, and genetic identification.
• Forensic Lab Construction Complete forensic laboratory construction services including design, equipment setup, and technical consulting for establishing forensic identification facilities, targeted at government and public-sector forensic agencies.
• Drug Abuse Test Products Drug abuse testing products for detecting substance use in clinical, workplace, and forensic settings, used by hospitals, clinics, occupational health providers, and forensic identification units.

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Domestic Universities and Research InstitutionscoreStrategic or Co-development PartnerLong-term cooperative relationships with many domestic universities and research institutions to jointly conduct research and application of cutting-edge technologies in gene sequencing and forensic identification.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• QIAGEN: Global leader in sample-prep and forensic DNA analysis kits (including former Verogen NGS-forensics business). Directly comparable to Superbio's forensic reagent kits and CE/FDA-cleared forensic workflow products.
• BGI Group: China-based genomics powerhouse with sequencing instruments, forensic DNA products and clinical genetic testing services. Directly comparable as a Chinese peer across both the sequencing-instrument and forensics verticals.
• Verogen (QIAGEN): Specializes in NGS-based forensic sequencing workflows (MiSeq FGx). Direct competitor in forensic human identification, particularly relevant as the forensic market transitions from CE to NGS.
• LGC Biosearch Technologies: Supplies oligonucleotide-based forensic and genomic analysis kits and instrumentation. Comparable as a reagent-kit and consumables peer in the forensics and molecular diagnostics workflow.
• Daan Gene (Da An Gene): Leading Chinese molecular diagnostics and genetic testing company with its own sequencing platforms and reagent kits. Comparable as a domestic Chinese competitor across the same medical/forensic customer base.
• Promega Corporation: Established manufacturer of forensic DNA quantification and STR analysis kits, directly comparable to Superbio's Y/X/A-series multiplex forensic reagent products serving crime labs.
• Annoroad Gene Technology: Chinese sequencing service and instrument provider focused on clinical genomics and forensics. Comparable product portfolio and target customers to Superbio's medical and forensic segments.

Broad incumbents

• Illumina: Dominant next-generation sequencing platform provider. Represents the technological trajectory (NGS) that Superbio's CE-based genetic analyzers and forensic kits must compete against or migrate to.
• Thermo Fisher Scientific: Operates the Applied Biosystems capillary electrophoresis genetic analyzers (e.g., 3500 series) and a broad forensic reagent portfolio. Closest incumbent competing head-to-head with Superbio's genetic analyzer and forensic kit lines.

Emerging players

• Hangzhou Ailing Gene Technology: Chinese developer of genetic analyzers and forensic DNA kits with overlapping SKUs (capillary electrophoresis platforms, multiplex STR kits). Comparable as an emerging domestic peer competing for the same Chinese forensic and clinical accounts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/jiangsu-superbio-biomedical-co-ltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jiangsu Superbio Biomedical Co., Ltd.